These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15595483)

  • 1. Inhaled short-acting beta2 agonist.
    Nurs Times; 2004 Nov 16-22; 100(46):31. PubMed ID: 15595483
    [No Abstract]   [Full Text] [Related]  

  • 2. Part IV: Genetic variations in beta2-adrenergic receptors: long-acting and short-acting beta2-agonists and therapeutic response.
    Peters S
    Curr Med Res Opin; 2007 Sep; 23 Suppl 3():S29-36. PubMed ID: 17925066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerability profiles of leukotriene receptor antagonists and long-acting beta2-adrenoceptor agonists in combination with inhaled corticosteroids for treatment of asthma: a review.
    Colucci R; Fornai M; Tuccori M; Antonioli L; Pasqualetti G; Blandizzi C; Del Tacca M
    J Asthma; 2007; 44(6):411-22. PubMed ID: 17654125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-acting beta2-adrenoceptor agonists: a smart choice for asthma?
    Lipworth BJ
    Trends Pharmacol Sci; 2007 Jun; 28(6):257-62. PubMed ID: 17466387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of combination long-acting beta-2 agonists and inhaled glucocorticosteroids for treatment of asthma.
    Kim D; Glaum M; Lockey R
    Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):933-40. PubMed ID: 19619072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cough and asthma: the role of inhaled corticosteroids and beta2-agonists.
    Cazzola M; Gabriella Matera M
    Ther Adv Respir Dis; 2008 Feb; 2(1):7-11. PubMed ID: 19124354
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk versus benefit considerations for the beta(2)-agonists.
    Kelly HW
    Pharmacotherapy; 2006 Sep; 26(9 Pt 2):164S-74S. PubMed ID: 16945063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bronchodilators: implications for nursing practice.
    Jordan S; White J
    Nurs Stand; 2001 Mar 21-27; 15(27):45-52; quiz 54-6. PubMed ID: 12216231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-adrenoceptor responses of the airways: for better or worse?
    Broadley KJ
    Eur J Pharmacol; 2006 Mar; 533(1-3):15-27. PubMed ID: 16469310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-acting beta-2 agonists in asthma.
    Med Lett Drugs Ther; 2009 Jan; 51(1303):1-2. PubMed ID: 19122566
    [No Abstract]   [Full Text] [Related]  

  • 11. Beta2 agonists in the treatment of asthma.
    Yawn B
    Am Fam Physician; 2006 Jul; 74(2):232. PubMed ID: 16883922
    [No Abstract]   [Full Text] [Related]  

  • 12. Achieving therapeutic benefits of inhaled corticosteroids/beta2 agonist in chronic obstructive airway disease.
    Wang ZL
    Chin Med J (Engl); 2007 Jun; 120(12):1097-105. PubMed ID: 17637229
    [No Abstract]   [Full Text] [Related]  

  • 13. Safety of long-acting beta2-agonists in the treatment of asthma.
    Cazzola M; Matera MG
    Ther Adv Respir Dis; 2007 Oct; 1(1):35-46. PubMed ID: 19124346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of beta agonists.
    Donohue JF
    Respir Care; 2008 May; 53(5):618-22; discussion 623-4. PubMed ID: 18426615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there a problem with inhaled long-acting beta-adrenergic agonists?
    Nelson HS
    J Allergy Clin Immunol; 2006 Jan; 117(1):3-16; quiz 17. PubMed ID: 16387577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is new with the beta2-agonists: issues in the management of asthma.
    Kelly HW
    Ann Pharmacother; 2005 May; 39(5):931-8. PubMed ID: 15811904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A safety review of long-acting beta2-agonists in patients with asthma.
    Rider NL; Craig TJ
    J Am Osteopath Assoc; 2006 Sep; 106(9):562-7. PubMed ID: 17079526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [beta2-Sympathomimetics: dangers in asthma therapy? Lessons from the SMART1 Study].
    Riedl-Seifert R
    Dtsch Med Wochenschr; 2007 Mar; 132(12):633; author reply 633-4. PubMed ID: 17357910
    [No Abstract]   [Full Text] [Related]  

  • 19. Paradoxical asthma hazard of short-acting beta2-agonists.
    Seed MJ; Agius RM
    Allergy; 2008 Feb; 63(2):241. PubMed ID: 18028244
    [No Abstract]   [Full Text] [Related]  

  • 20. Reply to Dr. Bisgaard.
    Chipps B
    Pediatr Pulmonol; 2004 Aug; 38(2):174; author reply 175-6. PubMed ID: 15211703
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.